Rifampicin-Associated DRESS Syndrome Followed by Rifabutin-Associated Hypopyon Uveitis in an Immunocompetent Patient with Mycobacterium Kansasii Infection
Abstract
PURPOSE: To describe a previously unreported pattern of sequential, severe hypersensitivity reactions to two rifamycin derivatives-rifampicin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) followed by rifabutin-induced bilateral sequential hypopyon uveitis-in the same immunocompetent patient treated for pulmonary Mycobacterium kansasii infection.
METHODS: Retrospective single-patient case description with clinical, laboratory, slit-lamp, and imaging evaluation, complemented by systemic and infectious workup including HLA-B27 typing.
RESULTS: A 45-year-old immunocompetent woman developed constitutional symptoms followed by a generalized maculopapular rash three weeks after starting standard antituberculosis therapy, subsequently extending to more than 50% of body surface area with eosinophilia, leukopenia, and elevated liver enzymes, fulfilling RegiSCAR criteria for probable DRESS. After drug discontinuation and systemic corticosteroids, her regimen was modified to clarithromycin, moxifloxacin, linezolid, and rifabutin via graded provocation. Five months later, she developed left-eye anterior uveitis with fibrinous exudate and posterior synechiae, which resolved with topical corticosteroids at an external center. Two months later, she presented with right-eye hypopyon uveitis (4+ anterior chamber reaction, fibrinous exudate, 1-mm hypopyon). Systemic and infectious workup, including HLA-B27, was negative. Rifabutin was discontinued, and topical and…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.